Please ensure Javascript is enabled for purposes of website accessibility

pharmaceutical industry

May 18, 2026

US Supreme Court rebuffs pharma challenge to Biden-era drug price

The U.S. Supreme Court declined to hear pharmaceutical companies' challenge to the Biden administration's Medicare drug price negotiation plan.

Verdicts & Settlements

See All Verdicts & Settlements

Opinion Digests

See All Digests